Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use

Vaccine

Volumn 15, Issue 14, 1997, Pages 1562-1567

  Ling, I T ^a   Ogun, S A ^a   Momin, P ^b   Richards, R L ^c   Garcon N ^b   Cohen, J ^b   Ballou, W R ^c   Holder, A A ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Adjuvant; Malaria; MSP 1; Plasmodium yoelii; Vaccine

Indexed keywords

ADJUVANT; FREUND ADJUVANT; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MALARIA VACCINE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNIZATION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; PROTECTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; IMMUNIZATION, PASSIVE; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PLASMODIUM YOELII; PROTEIN PRECURSORS; PROTOZOAN PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0030867015     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00076-5     Document Type: Article

References (38)

1. Diggs, C.L., Ballou, W.R. and Miller, L.H. The major merozoite surface protein as a malaria vaccine target. Parasitology Today 1993, 9, 300-302.
2. Blackman, M.J., Heidrich, H.-G., Donachie, S., McBride, J.S. and Holder, A.A. A single fragment of a malaria merozoite surface protein remains on the parasite surface during red cell invasion and is the target of invasion-inhibiting antibodies. Journal of Experimental Medicine 1990, 172, 379-382.
3. Blackman, M.J., Ling, I.T., Nicholls, S.C. and Holder, A.A. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Molecular and Biochemical Parasitology 1991, 49, 29-34.
4. Holder, A.A., Blackman, M.J., Burghaus, P.A., Chappel, J.A., Ling, I.T., McCallum-Deighton, N. and Shai, S. A malaria merozoite surface protein (MSP1) structure, processing and function. Memoirs of the Institute of Oswaldo Cruz 1992, 87, (Suppl. III), 37-42.
5. Kang, Y. and Long, C.A. Sequence heterogeneity of the C-terminal, cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Molecular and Biochemical Parasitology 1995, 73, 103-110.
6. Pirson, P.J. and Perkins, M.E. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. Journal of Immunology 1985, 134, 1946-1951.
7. Cooper, J.A., Cooper, L.T. and Saul, A.J. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA-1. Molecular and Biochemical Parasitology 1992, 51, 301-312.
8. Chang, S.P., Gibson, H.L., Leeng, C.T., Barr, P.J. and Hui, G.S.N. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. Journal of Immunology 1992, 149, 548-555.
9. Blackman, M.J., Scott-Finnigan, T.J., Shai, S. and Holder, A.A. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. Journal of Experimental Medicine 1994, 180, 389-393.
10. Majarian, W.R., Daly, T.M., Weidanz, W.P. and Long, C.A. Passive immunization against murine malaria with IgG3 monoclonal antibody. Journal of Immunology 1984, 132, 3131-3137.
11. Burns, J.M., Majarian, W.R., Young, J.F., Daly, T.M. and Long, C.A. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii. Journal of Immunology 1989, 143, 2670-2676.
12. Daly, T.M. and Long, C.A. A recombinant 15-kilodalton carboxyl terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein-1 induces a protective response in mice. Infection and Immunity 1993, 61, 2462-2467.
13. Ling, I.T., Ogun, S.A. and Holder, A.A. Immunisation against malaria with a recombinant protein. Parasite Immunology 1994, 16, 63-67.
14. Daly, T.M. and Long, C.A. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. Journal of Immunology 1995, 155, 236-243.
15. Holder, A.A., Freeman, R.R. and Nicholls, S.C. Immmunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunology 1988, 10, 607-617.
16. Kumar, S., Yadava, A., Keister, D.B., Tian, J.H., Ohl, M., Perdue-Greenfield, K.A., Miller, L.H. and Kaslow, D.C. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Molecular Medicine 1995, 1, 325-332.
17. Chang, S.P., Case, S.E., Gosnell, W.L., Hashimoto, A., Kramer, K.J., Tam, L.Q., Hashiro, C.Q., Nikaido, C.M., Gibson, H.L., Lee-Ng, C.T., Barr, P.J., Yokota, B.T. and Hui, G.S.N. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infection and Immunity 1996, 64, 253-261.
18. Playfair, J.H. and de Souza, J.B. Vaccination of mice against malaria with soluble antigens. 1. The effect of detergent, route of injection and adjuvant. Parasite Immunology 1986, 8, 409-414.
19. Kenney, J.S., Hughes, B.W., Masada, M.P. and Allison, A.C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. Journal of Immunological Methods 1989, 121, 157-166.
20. Lewis, A.P. Cloning and analysis of the gene encoding the 230-kDa merozoite surface antigen of Plasmodium yoelii. Molecular and Biochemical Parasitology 1989, 36, 271-282.
21. Smith, D.B. and Johnson, K.S. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988, 67, 31-40.
22. Alving, C.R., Shichijo, S., Mattsby-Baltzer, I., Richards, R.L. and Wassef, N.M. Preparation and use of liposomes in immunological studies. In Liposome Technology (Ed. Gregoriadis, G.), 2nd edition, Vol. 3. CRC Press, Boca Raton, FL, 1993, pp. 317-343.
23. Stoute, J.A., Slaoui, M., Heppner, G.D., Momin, P., Kester, K.E., Desmons, P., Wellde, B.T., Garçon, N., Krzych, U., Marchand, M., Ballou, W.R. and Cohen, J.D. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. New England Journal of Medicine 1997, 336, 86-91.
24. Ribi, E., Ulrich, J.T. and Mashi, K.N. Immunopotentiating activities of monophosphoryl lipid A. In Immunopharmacology of Infectious Diseases: Vaccine Adjuvants and Modulators of Non-specific Resistance (Ed. Majde, J.A.). Alan R. Liss, New York, 1993, pp. 101-112.
25. Kensil, C.R., Patel, U., Lennick, M. and Marciani, D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. Journal of Immunology 1991, 146, 431-437.
26. Freeman, R.R. and Holder, A.A. Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen. Clinical and Experimental Immunology 1983, 54, 609-616.
27. Holder, A.A. and Freeman, R.R. Characterization of a high molecular weight protective antigen of Plasmodium yoelii. Parasitology 1984, 88, 211-219.
28. Freeman, R.R. and Parish, C.R. Plasmodium yoelii: antibody and maintenance of immunity in BALB/c mice. Experimental Parasitology 1981, 52, 18-24.
29. Taylor, D.W., Pacheco, E., Evans, C.B. and Asofsky, R. Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype response. Parasite Immunology 1988, 10, 33-46.
30. White, W.I., Evans, C.B. and Taylor, D.W. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infection and Immunity 1991, 59, 3547-3554.
31. Wechsler, D.S. and Kongshavn, P.A. Heat-labile IgG2a antibodies affect cure of Trypanosoma musculi infection in C57BL/6 mice. Journal of Immunology 1986, 137, 2968-2972.
32. ten Hagen, T.L.M., Sulzer, A.J., Kidd, M.R., Lal, A.A. and Hunter, R.L. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. Journal of Immunology 1993, 151, 7077-7085.
33. Hunter, R.L., Kidd, M.R., Olsen, M.R., Patterson, P.S. and Lal, A.A. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. Journal of Immunology 1995, 154, 1762-1769.
34. Ling, I.T., Ogun, S.A. and Holder, A.A. The two epidermal growth factor-like modules of Plasmodium yoelii merozoite surface protein-1 are required for an effective immune response to the parasite. Parasite Immunology 1995, 17, 425-433.
35. Golding, B., Zaitseva, M. and Golding, H. The potential for recruiting immune responses towards type 1 or type 2 T cell help. American Journal of Tropical Medicine and Hygiene 1994, 50, 33-40.
36. Daly, T.M. and Long, C.A. Influence of adjuvants on protection induced by a recombinant fusion protein against malaria infection. Infection and Immunity 1996, 64, 2602-2608.
37. de Souza, J.B., Ling, I.T., Ogun, S.A., Holder, A.A. and Playfair, J.H.L. Cytokines and antibody subclass associated with protective immunity against blood stage malaria in mice vaccinated with the C-terminus of merozoite surface protein 1 plus a novel adjuvant. Infection and Immunity 1996, 64, 3532-3536.
38. Tian, J.-H., Miller, L.H., Kaslow, D.C., Ahlers, J., Good, M.F., Alling, D.W., Berzofsky, J.A. and Kumar, S. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. Journal of Immunology 1996, 157, 1176-1183.